drugset / Trial / NCT05819619

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

NCT05819619

Phase 0 Terminated 8 enrolled Hackensack Meridian Health
RandomizedParallel-groupOpen-labelPrevention

Summary

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Timeline

Start
2023-07-20
Primary completion
2024-04-01
Completion
2024-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule
Subject Ondansetron Other / unclassified

Indications

No indication recorded.